MAKO Surgical Corp (MAKO) Financials

$10.08

$0.26 (2.65%)

As on 11-Sep-2026 16:00EDT

Market cap

$892 Mln

Revenue (TTM)

$208 Mln

P/E Ratio

17.6

P/B Ratio

4.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	207.57	148.47	92.08	65.95	63.38	--
Cost of Revenue	99.94	73.46	45.69	41.94	51.34	--
Gross Profit	107.64	75.02	46.39	24.01	12.04	--
Operating Expenses	23.17	20.76	12.11	1.17	2.20	--
Operating Profit (EBIT)	84.46	54.26	34.28	22.84	9.84	--
Other Income	--	--	--	--	--	--
Profit before Tax	83.59	54.70	29.35	8.88	-9.88	--
Provision for Tax	31.44	20.96	10.20	2.08	2.10	--
Profit after Tax (Net Income)	52.16	33.74	19.15	6.80	-11.98	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	190.04	150.73	76.92	20.63	13.67	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	55.77	28.86	13.56	11.52	15.35	--
Current Liabilities	50.34	28.85	16.60	9.66	16.16	--
Total Liabilities	346.49	208.45	107.08	41.81	45.17	--

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	139.74	96.72	79.71	25.10	32.27	--
Current Assets	156.41	111.72	27.37	16.71	12.90	--
Total Assets	346.36	208.45	107.08	41.81	45.17	--
Total Debt*	41.69	0.07	4.97	7.77	12.98	--
Net Current Assets	106.20	82.87	10.77	7.06	-3.25	--

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	52.98	34.45	12.47	16.38	--
Cash Flow from Investing Activities	--	-20.34	-13.19	-4.76	-8.80	--
Cash from Financing Activities	--	30.07	-8.23	-6.75	-8.99	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.58	0.38	0.24	--	--	--
Cash EPS ($)	--	0.47	0.34	--	--	--
Adjusted Book Value ($)	--	1.69	0.97	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.59	0.43	--	--	--
Free Cash Flow per Share ($)	--	0.45	0.27	--	--	--

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	29.00	34.73	24.70	--	--
ROE (%)	30.61	29.64	39.27	39.65	--	--
ROA (%)	20.59	21.39	25.73	15.63	--	--
EBIT Margin (%)	41.30	37.52	32.72	14.89	-12.94	--
Net Margin (%)	25.13	22.72	20.80	10.31	-18.90	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	0.61	0.40	0.04	--	--
EBIT Growth (%)	--	84.92	206.78	219.71	--	--
Net Profit Growth (%)	--	76.17	181.69	156.77	--	--
EPS Growth (%)	--	0.56	--	--	--	--
Book Value Growth (%)	77.13	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	17.55	15.37	9.14	--	--	--
Price / Book Value	4.41	3.44	2.28	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	7.84	6.90	4.38	--	--	--
Close Price ($)	7.31	5.80	2.21	2.05	1.00	--
High Price ($)	8.99	6.31	2.85	2.10	3.20	--
Low Price ($)	3.62	2.22	1.49	0.85	0.80	--
Market Cap ($ Cr)	891.83	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.00	0.06	0.38	0.95	--
Short term debt to equity ratio	0.07	0.00	0.00	0.00	0.03	--
Current Ratio	3.11	3.87	1.65	1.73	0.80	--
Quick Ratio	2.35	2.86	0.98	0.30	0.18	--
Interest Coverage	109.90	55.05	38.77	10.48	-4.89	--

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	0.55	1.38	0.41	0.77	1.86	--
Asset Turnover	0.82	0.94	1.24	1.52	--	--
Receivable days	--	2.99	1.77	4.68	6.80	--
Inventory Days	--	100.11	99.67	103.72	70.94	--
Payable days	--	59.08	63.82	73.24	77.53	--
Cash Conversion Cycle	--	44.01	37.62	35.16	0.21	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.